Michael Daley

Michael Daley has over 20 years of experience in the pharmaceutical and biotech industry. Michael is currently the CEO and founder of OrthogenRx, a company that specializes in licensing ex-U.S. approved products and taking advantage of an accelerated approval process. Prior to OrthogenRx, Michael was the president and CEO of OrthogenRx, Inc., a company they founded based on the business strategy of licensing ex-U.S. approved products. Michael has also served as a principal consultant at Cognate Consultants LLC, where they offered clients consulting services in drug discovery, drug development, peri-approval and post-marketing, and business development.

Some direct reports include Ken Long - VP, Market Access & Key Accounts, Lynne Budnovitch - SVP, Operations & Compliance, and Ashley Wohl - VP, Marketing.